IMCAS Innovation Shark Tank 2019

IMCAS Annual World Congress 2019 marked the debut of the first edition of the IMCAS Global Market Summit, a day comprised of three events gathering all international players in the dermatology, plastic surgery and aesthetic market.

One of these three events was the Innovation Shark Tank, where 13 of the most promising start-ups from around the world pitched their original products to a high-profile jury. The start-up who proposed the most innovative solution among the competitors was selected to win the Innovation of the Year award.

The Winner of the 2019 Innovation of the Year Award

CHERRY IMAGING "IMCAS Innovation of the Year 2019" Award Winner
Cherry Imaging’s cutting-edge camera and technology brings long-awaited scientific data to the hands of physicians for accurate, objective, and traceable treatments on both face and body. This imaging platform combines a powerful, easy-to-use 3D camera with innovative Trace™ software that together can objectively measure changes in skin — from scars, fillers and botox, to skin rejuvenation and full body scans. The lightweight, handheld camera captures thousands of three-dimensional images from multiple field views and multiple angles, all within a single, one-click scan. The images can be captured from wherever the physician is with the patient — no lighting adjustments or angling necessary for easy, portable scanning. Cherry provides doctors and patient with accurate feedback for comparable analyses over time. Whether the data is being used immediately or for traceability, doctors and their patients and the industry can now see pre- and post-treatment results with a purely objective lens.
More information on Cherry Imaging's website

Applause for the Two Runner-ups

SOLTÉGO "Promising Innovation" Award
Soltégo is a bio-pharmaceutical company which has developed a disruptive patented technology: a Salt Inducable Kinase inhibitor. When applied topically, this inhibitor triggers the melanin production pathway, and causes a natural tan and darkening of the skin – without exposure to UV light. In preliminary studies, Soltégo’s technology has been shown to be safe and effective. Soltégo is currently developing 2 parallel products: a cosmetic directed towards consumers seeking sun protection/natural tanning of their skin, and an RX product indicated for pigmentation disorders/patients with high sensitivity to UV light.
More information on Soltégo's website

SEEVIX "Promising Innovation" Award
Seevix produces SVX™, the first true man-made spidersilk, which combines excellent mechanical properties with high biocompatibility, non-immunogenicity, and micrometric architecture, yielding a unique biomaterial for cosmetics and dermatology applications. SVX is a protein based biomaterial enabling various modifications and modulations for custom made engineered scaffolds. SVX has been demonstrated to support true 3D cell growth providing mechanical support, improving cell viability, conserving cell function over time and delaying cell death. Thus, it is an excellent scaffold for skin regeneration and tissue engineering. Additionally, SVX’s exceptional strength, unique adhesive properties, elasticity, stability and biocompatibility make it an ideal topical smoothing agent for advanced skin products. SVX can be applied for coating or soaking with slow-release bio-active molecules, such as nutrients, oils and pigments, to maintain skin health and stimulate repair as well as to retain hydration and protect skin from light, oxidation and degradation.
More information on Seevix's website

Collaborators of Innovation Shark Tank

A special thanks to the following organizations for their support:
• Advancing Innovation in Dermatology
• Masters of Aesthetics Congress
• MIT Hacking Medicine Institute